News | June 30, 2024
ONGC to enhance healthcare facilities at Baltal and Chandanwari in J&K
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
This initiative underscores a steadfast commitment of ONGC to sustainable development and enhanced public health services
Signs MoUs with Shri Krishna Ayush University and Dabur India
This tie-up will have no impact on any other brands of the company
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
Berlinger brings a suite of proprietary and high-quality hardware and software solutions that broaden Sensitech's end-to-end cold chain monitoring product portfolio
Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
Subscribe To Our Newsletter & Stay Updated
